Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
16.00
+0.83 (5.47%)
At close: Jun 6, 2025, 4:00 PM
16.70
+0.70 (4.37%)
After-hours: Jun 6, 2025, 6:56 PM EDT

Benitec Biopharma Income Statement

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Jun '24 Jun '23 Jun '22 Jun '21 Jun '20 2015 - 2019
Operating Revenue
--0.080.070.060.1
Upgrade
Revenue
--0.080.070.060.1
Upgrade
Revenue Growth (YoY)
--2.74%23.73%-42.16%-99.16%
Upgrade
Cost of Revenue
--0.11-0.010.12-0.19
Upgrade
Gross Profit
-0.110.080.06-0.060.29
Upgrade
Selling, General & Admin
11.996.996.386.656.515.57
Upgrade
Research & Development
18.1515.6112.7711.277.023
Upgrade
Operating Expenses
30.1422.619.1617.9213.538.57
Upgrade
Operating Income
-30.14-22.49-19.08-17.85-13.6-8.28
Upgrade
Interest Expense
---0.03-0.03-0.01-
Upgrade
Interest & Investment Income
3.170.9---0.06
Upgrade
Currency Exchange Gain (Loss)
-0.130.04-0.42-0.23-0.33-0.09
Upgrade
Other Non Operating Income (Expenses)
-0.16-0.2-0.03-0.08--
Upgrade
EBT Excluding Unusual Items
-27.25-21.75-19.56-18.2-13.94-8.31
Upgrade
Gain (Loss) on Sale of Investments
--0-0-0.010.02-0
Upgrade
Other Unusual Items
0.76---0.040.03
Upgrade
Pretax Income
-26.49-21.75-19.56-18.21-13.88-8.27
Upgrade
Net Income
-26.49-21.75-19.56-18.21-13.88-8.27
Upgrade
Preferred Dividends & Other Adjustments
-0.62----
Upgrade
Net Income to Common
-26.49-22.37-19.56-18.21-13.88-8.27
Upgrade
Shares Outstanding (Basic)
1841000
Upgrade
Shares Outstanding (Diluted)
1841000
Upgrade
Shares Change (YoY)
46.71%192.98%188.30%90.24%320.63%19.19%
Upgrade
EPS (Basic)
-1.47-5.51-14.12-37.88-54.94-137.74
Upgrade
EPS (Diluted)
-1.47-5.51-14.12-37.88-54.94-137.74
Upgrade
Free Cash Flow
-18.69-19.58-18.01-15.91-13.05-7.63
Upgrade
Free Cash Flow Per Share
-1.03-4.82-13.00-33.10-51.66-127.02
Upgrade
Gross Margin
--100.00%87.67%-108.47%281.37%
Upgrade
Operating Margin
---25441.33%-24457.53%-23044.07%-8118.63%
Upgrade
Profit Margin
---26082.67%-24942.47%-23528.81%-8111.76%
Upgrade
Free Cash Flow Margin
---24017.33%-21797.26%-22123.73%-7480.39%
Upgrade
EBITDA
-30.06-22.4-18.95-17.69-13.37-8.09
Upgrade
D&A For EBITDA
0.080.090.140.170.230.19
Upgrade
EBIT
-30.14-22.49-19.08-17.85-13.6-8.28
Upgrade
Revenue as Reported
-----0.1
Upgrade
Updated May 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q